The Blavatnik Family Women’s Health Research Institute is sponsored by Mount’s Sinai’s Department of Obstetrics, Gynecology, and Reproductive Science and co-sponsored by the Department of Population Health Science and Policy. The goal of the Institute is to build a competitive research program and advance science as it relates to women’s health across the life course.
Our research agenda spans the spectrum of translational research and focuses on common and highly impactful health conditions that end the lives of women prematurely and significantly reduce their quality of life. Our research focus also spans the life course, from pregnancy complications such as eclampsia and gestational diabetes, to chronic illnesses such as Type 2 diabetes and depression, to gynecologic cancers.
The Blavatnik Family Women’s Health Research Institute celebrates Pride Month and is committed to advancing quality healthcare for the LGBTQ+ community.
Under the leadership of Elizabeth Howell, MD, MPP, Director of The Blavatnik Family Women’s Health Research Institute, we are reaching out to other leaders within the Mount Sinai Health System who share a common interest and goals in women’s health. In addition, the Institute has a Scientific Advisory Board which includes experts from both inside and outside the Mount Sinai Health System.
Internal Scientific Advisory Board
The Internal Scientific Advisory Board, co-chaired by Michael Brodman, MD and Annetine Gelijns, PhD, JD, includes Mount Sinai senior faculty. The board plays an instrumental role in guiding the direction and growth of The Blavatnik Family Women’s Health Research Institute.
External Advisory Board
The Institute is recruiting for the leadership of this center.